Patients with axial psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) plus psoriasis differ with respect to clinical and genetic characteristics, according to the findings of a recent ...
Please provide your email address to receive an email when new articles are posted on . Axial involvement in psoriatic arthritis is associated with a greater risk for moderate-to-severe psoriasis, ...
—Researchers in Canada compared isolated axial psoriatic arthritis, axial PsA with peripheral involvement, and isolated axial ankylosing spondylitis with psoriasis, to determine which factors predict ...
Psoriasis developed in 1 in 4 patients with axial spondyloarthritis (axSpA) across a 6-year span, in which those with both conditions reported greater joint involvement and biologic use than those ...
Patients with psoriasis, uveitis, or colitis who present with undiagnosed chronic back pain should be referred to a rheumatologist for the assessment of axial spondyloarthritis (axSpA), with MRI being ...
Please provide your email address to receive an email when new articles are posted on . Patients with axial spondyloarthritis and psoriatic arthritis routinely “bounce” from one provider to the next ...
Patients with axSpA can wait 10 years after symptom onset to be diagnosed with the condition. There are currently no guidelines to advise clinicians on when to refer to a rheumatologist, and with the ...
First regulatory submissions for bimekizumab in psoriatic arthritis and axial spondyloarthritis worldwide Brussels (Belgium), 20th September 2022 – 07:00 (CEST) – UCB, a global biopharmaceutical ...
Sustained improvements across stringent measures of disease in patients with psoriatic arthritis (PsA): One-year improvements were sustained to three years across measures of peripheral arthritis, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results